Feasibility of a Music Therapy Intervention to Decrease Stress During Pediatric Critical Care

February 1, 2022 updated by: Jessica Jarvis, University of Pittsburgh

Admission into a pediatric intensive care unit (PICU) is a highly stressful experience for child and family. High levels of stress can negatively impact outcomes, yet non-pharmacological interventions to decrease stress in the PICU are severely lacking. This is a prospective, single-arm feasibility trial that will explore the feasibility and acceptability of a music therapy intervention to decrease stress in the PICU among families of children receiving invasive or noninvasive mechanical ventilation.

Objectives: The aims of this study are to: 1) Assess the feasibility of implementing a music therapy intervention in the PICU among children receiving invasive or non-invasive mechanical ventilation; 2) Determine the acceptability of the music therapy intervention in the ICU among caregivers, patients, and pediatric and cardiac ICU staff; 3) Explore the variability in child and caregiver stress outcomes throughout ICU admission. Hypothesis: The music therapy intervention will be feasible, as determined by recruitment, retention, protocol adherence, and data collection rates, and will be acceptable to participants and to PICU staff.

Sample: This study will recruit 20 families that include children aged 2 months - 17 years old admitted with an expected length of ICU stay greater than 72 hours. Of these 20 families, the investigators will specifically recruit 10 families whose child is admitted for a hypoxic brain injury. Eligible children are receiving either noninvasive mechanical ventilation (i.e., continuous or bilevel positive airway pressure), invasive mechanical ventilation, or have an established tracheostomy tube and with escalated support settings. One primary caregiver will be enrolled along with the child admitted into the ICU.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15224
        • UPMC Children's Hospital of Pittsburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 months to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Parent/caregiver aged 18 years or older.
  • Children aged 2 months - 17 years admitted to the PICU with an expected length of stay greater than 72 hours
  • Child is receiving either noninvasive mechanical ventilation (i.e., continuous or bilevel positive airway pressure), invasive mechanical ventilation, or have an established tracheostomy tube and with escalated support setting

Exclusion Criteria:

  • The legal guardian is unclear,
  • Caregiver does not read, write, and speak English
  • Child is not expected to survive that PICU stay or has care limitations in place
  • Child has deafness in both ears, in foster care or justice system, or experiences musicogenic epilepsy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music therapy
Music listening intervention provided by a board certified music therapist.
Patient preferred song will be provided in a sedative manor (e.g., 60-80 beats per minute) using live music (singing with guitar accompaniment) by a board certified music therapist.
Other Names:
  • Music listening

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of participant recruitment
Time Frame: Throughout study completion, anticipated 1 year
Feasibility of participant recruitment will be determined via recruitment rate
Throughout study completion, anticipated 1 year
Feasibility of participant retention
Time Frame: Post-intervention completion, anticipated 2 weeks
Feasibility of participant retention will be determined via retention
Post-intervention completion, anticipated 2 weeks
Feasibility of protocol
Time Frame: Throughout study completion, anticipated 1 year
Feasibility of protocol will be determined via percentage of sessions that adhere to protocol
Throughout study completion, anticipated 1 year
Feasibility of data collection
Time Frame: Throughout study completion, anticipated 1 year
Feasibility of data collection will be determined via percentage of participants with complete data capture
Throughout study completion, anticipated 1 year
Acceptability of intervention among participants
Time Frame: Post-intervention, anticipated 2 weeks
Acceptability will be assessed via interviews with participants (caregivers and children 8 years and older) to ascertain intervention benefits, barriers, and potential optimizations.
Post-intervention, anticipated 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in heart rate
Time Frame: Throughout intervention completion, anticipated 2 weeks
Change in child participant heart rate during intervention
Throughout intervention completion, anticipated 2 weeks
Change in oxygen saturation
Time Frame: Throughout intervention completion, anticipated 2 weeks
Change in child participant oxygen saturation during intervention
Throughout intervention completion, anticipated 2 weeks
Change in blood pressure
Time Frame: Throughout intervention completion, anticipated 2 weeks
Change in child participant blood pressure during intervention
Throughout intervention completion, anticipated 2 weeks
Change in saliva cortisol
Time Frame: Throughout intervention completion, anticipated 2 weeks
Change in child and caregiver participant saliva cortisol levels pre-post intervention
Throughout intervention completion, anticipated 2 weeks
Change in saliva inflammatory biomarkers
Time Frame: Throughout intervention completion, anticipated 2 weeks
Change in child participant saliva inflammatory biomarker levels pre-post intervention
Throughout intervention completion, anticipated 2 weeks
Visual Analog Scale - Anxiety
Time Frame: Throughout intervention completion, anticipated 2 weeks
Change in caregiver participant self-reported anxiety pre-post intervention. 0-100, higher score indicates greater anxiety level.
Throughout intervention completion, anticipated 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jessica M Jarvis, PhD, University of Pittsburgh

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2020

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

February 1, 2022

Study Registration Dates

First Submitted

February 19, 2020

First Submitted That Met QC Criteria

February 19, 2020

First Posted (Actual)

February 21, 2020

Study Record Updates

Last Update Posted (Actual)

February 3, 2022

Last Update Submitted That Met QC Criteria

February 1, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Music therapy

Subscribe